Immunohistochemistry
Geneticimmunohistochemical staining of colorectal carcinoma specimens by anti human fascin antibody.
NCT Number: NCT05553080
Colorectal carcinoma is a major health problem. As a malignant tumor, the malignant potential of colorectal carcinoma is based mainly on its ability to metastasis to different sites. Fascin-1 is an actin binding protein which is involved in reconstruction of intracellular actin network, the latter enforces the neoplastic cell to invade surrounding structures.
Looking for future studies?
Notify Me30 year–90 year
All sexes
Observational
Maisa Hashem Mohammed, Sohag, Egypt
colorectal carcinoma is an aggressive malignant tumor. It has high incidence of cancer-related morbidity and mortality. the malignant potential of a given neoplasm is based mainly on its ability to invade the surrounding vasculature and reach to distant sites, the latter is called metastasis. in order to metastasize to distant sites, the neoplastic cells must re-arrange the intracellular actin filaments into well formed intracellular assembly which enable the neoplastic cells to reach to distant sites. Fascin-1 is an actin binding protein, it is involved in reconstruction of actin assembly. fortunately, Fascin-1 could be blocked by newly developed medications, blocking of Fascin-1 may limit the metastasis of colorectal carcinoma. in current study the investigators detect Fascin-1 in colorectal carcinoma by immunohistochemical approach, then they correlated different levels of Fascin-1 expression to tumor clinical and pathological criteria as patients' ages, sexes, tumor stages, nodal metastasis, vascular and per-ineural invasions.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
immunohistochemical staining of colorectal carcinoma specimens by anti human fascin antibody.
Time frame: September , 2022
correlation of different levels of Fascin-1 expression to patients' ages, sexes, tumor stage, nodal metastasis, vascular and perineural invasion.
Sohag University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06035731
Anxiety Depression, Breast Diseases
Nice, France
View Trial DetailsNCT05982184
Anxiety, Anxiety Disorders
Breda, North Brabant, Netherlands
View Trial DetailsNCT05887531
Adnexal Diseases, Cancer of Colon
Castellon, Castellón, Spain
View Trial DetailsNCT04028479
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Idaho Falls, Idaho, United States
View Trial Details